Zhigang Wang

11PUBLICATIONS
45CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisMedical biotechnology diagnostics (incl. biosensors)Precision engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 08, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease.

Wei Zhang, Zhigang Wang, Thierry Dervieux

|Mar 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.

Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif

|Apr 07, 2025
A Risk Stratification Tool for Relapse After Intravenous-To-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases.

Yannick Hoffert, Zhigang Wang, Mathurin Fumery

|Feb 26, 2025
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease.

Andres J Yarur, Thierry Dervieux, Ryan Ungaro

|Apr 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang

|Aug 26, 2023
Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle.

Zhigang Wang, Erwin Dreesen

Pageof 2

Frequent Collaborators

11 joint publications

Erwin Dreesen

5 joint publications

Séverine Vermeire

4 joint publications

Marc Ferrante

2 joint publications

Konstantinos Papamichael